Cargando…
Case report: A rare case of Rosai–Dorfman–Destombes disease after the COVID-19 infection
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is known to cause immune dysregulation and, therefore, has varied and often rare presentations. Rosai–Dorfman–Destombes disease (RDD) is an unusual non-Langerhans cell (non-LC) histiocytosis pr...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806133/ https://www.ncbi.nlm.nih.gov/pubmed/36600887 http://dx.doi.org/10.3389/fmed.2022.1073767 |
_version_ | 1784862469623119872 |
---|---|
author | Gogia, Pooja Tanni, Fahmina Coca-Guzman, Juan Chen, Neil Huang, Yiwu |
author_facet | Gogia, Pooja Tanni, Fahmina Coca-Guzman, Juan Chen, Neil Huang, Yiwu |
author_sort | Gogia, Pooja |
collection | PubMed |
description | Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is known to cause immune dysregulation and, therefore, has varied and often rare presentations. Rosai–Dorfman–Destombes disease (RDD) is an unusual non-Langerhans cell (non-LC) histiocytosis presenting with massive lymphadenopathy and various systemic symptoms. A 55-year-old Asian-American woman with no significant medical history or recent use of new drugs initially presented with cervical lymphadenopathy and urticarial rash 1 week after receiving the COVID-19 messenger RNA (mRNA) vaccine (Moderna, mRNA-1273) against SARS-CoV-2. The biopsy of the skin rash was consistent with a drug reaction. Approximately 2 months later, she developed mild flu-like symptoms and was diagnosed with a COVID-19 infection. Her symptoms were mild and self-resolving. Approximately 3 months later, she developed a generalized patchy erythematous rash on the face and the body that gradually worsened; diffuse lymphadenopathy involving the bilateral cervical, axillary, and inguinal areas; and constitutional symptoms. Laboratory results were consistent with lymphopenia, anemia, and an elevated sedimentation rate. Supraclavicular lymph node biopsy showed Rosai–Dorfman disease with a marked polyclonal plasmacytosis. She was started on a tapering dose of corticosteroids and showed clinical improvements over the next few weeks. Herein, we present a rare case of a histiocytic disorder that developed after contracting the SARS-COV2 infection in the event of receiving a recent mRNA COVID vaccination. |
format | Online Article Text |
id | pubmed-9806133 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98061332023-01-03 Case report: A rare case of Rosai–Dorfman–Destombes disease after the COVID-19 infection Gogia, Pooja Tanni, Fahmina Coca-Guzman, Juan Chen, Neil Huang, Yiwu Front Med (Lausanne) Medicine Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is known to cause immune dysregulation and, therefore, has varied and often rare presentations. Rosai–Dorfman–Destombes disease (RDD) is an unusual non-Langerhans cell (non-LC) histiocytosis presenting with massive lymphadenopathy and various systemic symptoms. A 55-year-old Asian-American woman with no significant medical history or recent use of new drugs initially presented with cervical lymphadenopathy and urticarial rash 1 week after receiving the COVID-19 messenger RNA (mRNA) vaccine (Moderna, mRNA-1273) against SARS-CoV-2. The biopsy of the skin rash was consistent with a drug reaction. Approximately 2 months later, she developed mild flu-like symptoms and was diagnosed with a COVID-19 infection. Her symptoms were mild and self-resolving. Approximately 3 months later, she developed a generalized patchy erythematous rash on the face and the body that gradually worsened; diffuse lymphadenopathy involving the bilateral cervical, axillary, and inguinal areas; and constitutional symptoms. Laboratory results were consistent with lymphopenia, anemia, and an elevated sedimentation rate. Supraclavicular lymph node biopsy showed Rosai–Dorfman disease with a marked polyclonal plasmacytosis. She was started on a tapering dose of corticosteroids and showed clinical improvements over the next few weeks. Herein, we present a rare case of a histiocytic disorder that developed after contracting the SARS-COV2 infection in the event of receiving a recent mRNA COVID vaccination. Frontiers Media S.A. 2022-12-19 /pmc/articles/PMC9806133/ /pubmed/36600887 http://dx.doi.org/10.3389/fmed.2022.1073767 Text en Copyright © 2022 Gogia, Tanni, Coca-Guzman, Chen and Huang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Gogia, Pooja Tanni, Fahmina Coca-Guzman, Juan Chen, Neil Huang, Yiwu Case report: A rare case of Rosai–Dorfman–Destombes disease after the COVID-19 infection |
title | Case report: A rare case of Rosai–Dorfman–Destombes disease after the COVID-19 infection |
title_full | Case report: A rare case of Rosai–Dorfman–Destombes disease after the COVID-19 infection |
title_fullStr | Case report: A rare case of Rosai–Dorfman–Destombes disease after the COVID-19 infection |
title_full_unstemmed | Case report: A rare case of Rosai–Dorfman–Destombes disease after the COVID-19 infection |
title_short | Case report: A rare case of Rosai–Dorfman–Destombes disease after the COVID-19 infection |
title_sort | case report: a rare case of rosai–dorfman–destombes disease after the covid-19 infection |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806133/ https://www.ncbi.nlm.nih.gov/pubmed/36600887 http://dx.doi.org/10.3389/fmed.2022.1073767 |
work_keys_str_mv | AT gogiapooja casereportararecaseofrosaidorfmandestombesdiseaseafterthecovid19infection AT tannifahmina casereportararecaseofrosaidorfmandestombesdiseaseafterthecovid19infection AT cocaguzmanjuan casereportararecaseofrosaidorfmandestombesdiseaseafterthecovid19infection AT chenneil casereportararecaseofrosaidorfmandestombesdiseaseafterthecovid19infection AT huangyiwu casereportararecaseofrosaidorfmandestombesdiseaseafterthecovid19infection |